Inductive Bio builds AI-powered virtual laboratories designed for drug discovery teams. The company's platform enables researchers to evaluate chemistry ideas at a scale not previously possible, allowing teams to run millions of in silico experiments to accelerate the assessment of potential drug candidates.
A core product is the Beacon-1 class of AI models, built specifically for real-world heterogeneous ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) data. This system maps drivers of small molecule ADMET by combining a proprietary pre-competitive data consortium with machine learning techniques. Its efficacy is demonstrated by winning first place in the world's largest ADMET prediction competitions, outperforming over 370 submissions from leading pharmaceutical and technology companies.
The company operates at the intersection of AI/ML and chemistry. Its approach pairs human chemists with AI chemistry assistants, focusing on applications within the drug discovery and pharmaceutical industry verticals.
